MerckRecent
October 1, 2026Hospital and CH CEs: pharmacy and medical CLD for in-house pharmacy dispenses of Table 1 products via 340B ESP within 45 days.
Merck 340B In-House Pharmacy Claims Data Policy (Sept 23, 2026) on 340B ESPIn-house pharmacy medical claims submissions
We handle in-house pharmacy medical claims submissions.
Aventi handles your in-house pharmacy medical claims submissions to Beacon and manufacturer-required channels. $750 per covered entity per month also includes 2027 340B rebate claim submissions and 340B ESP and Truzo claims data submissions. Already an Aventi TPA client? All of this is included; the price is for covered entities that use another TPA.
$750/month
Per covered entity, per month. Flat fee.
Includes 2027 rebate claims and 340B ESP/Truzo claims data.
Your own pharmacy now has a claims job.
More manufacturers, more portals
A growing list of manufacturers now condition 340B pricing on claims data from in-house pharmacy dispenses, not just contract pharmacies.
Every policy is different
Products, data fields, deadlines (often 45 days), and exemptions vary by manufacturer and change often.
Missed files cost pricing
If data is late or missing, a manufacturer can withhold 340B pricing on its drugs.
What we take off your plate.
- Handle in-house pharmacy medical claims submissions to Beacon.
- Submit claims to manufacturers with added requirements (via 340B ESP and other required channels).
- Monitor manufacturer notices and update your submissions when policies change.
- Flag rejected or missing submissions before they become pricing problems.
- Works alongside your current TPA; no switch needed.
How it works.
1
Short kickoff call
We confirm your pharmacy system, NDCs, and which manufacturers apply to you.
2
Connect your data
We set up a secure claims feed from your pharmacy system.
3
We submit on schedule
Beacon and manufacturer submissions go out on each required timeline.
4
You stay informed
A simple status view and alerts when a manufacturer changes its rules.
Manufacturer requirements
16 manufacturers require in-house pharmacy claims
Last updated: October 1, 2026
Recent = effective on or after July 1, 2026.
Johnson & JohnsonRecent
September 15, 2026All CE types (except Ryan White Part B ADAPs): claims data for every 340B J&J dispense/administration regardless of location, via 340B ESP within 45 days (60 for listed products).
J&J 340B Claims Data Submission Policy (Sept 4, 2026) on 340B ESPGenentechRecent
August 31, 2026Universal claims data: all CEs submit CLD for in-house pharmacy, outpatient facility, and CP dispenses/administrations via 340B ESP.
Genentech 340B policy on 340B ESPBoehringer IngelheimRecent
July 6, 2026All CE types: pharmacy and medical claims data on 340B utilization filled at in-house pharmacies via 340B ESP within 45 days.
BI In-House Claims Collection Policy (June 17, 2026) on 340B ESPNovartisRecent
July 6, 2026All CEs: pharmacy and medical CLD for in-house pharmacy/entity-designated address dispenses of Novartis drugs via 340B ESP within 45 days.
Novartis 340B In-house Pharmacy Policy (July 9, 2026) on 340B ESPGSKRecent
July 1, 2026All CE types: in-house and contract pharmacy claims-level data for all dispensed GSK products via 340B ESP within 45 days.
GSK 340B Policy (June 5, 2026), hosted by CencoraSobiRecent
July 1, 2026All CEs: claims data for all 340B utilization (incl. in-house pharmacy dispenses) of Doptelet, Kineret, and Vonjo via 340B ESP within 45 days.
Sobi 340B policy (published June 8, 2026) on 340B ESPSanofi
June 15, 2026Claims data (pharmacy and medical) for entity-owned (in-house) pharmacies for CAH, DSH, RRC, SCH, CH, and now children's and free-standing cancer hospitals.
Sanofi 340B integrity initiative update (June 1, 2026) on 340B ESPAmgen
June 1, 2026All CE types: claims-level data for all 340B pharmacy and medical dispenses (in-house and CP), all products; healthcare visit and service claims data added Nov 15, 2026.
Amgen 340B policy (modified May 15, 2026) on 340B ESPBiogen
June 1, 2026All CE types: pharmacy CLD for all 340B dispenses of specified products (Avonex, Plegridy, Tecfidera, Vumerity), incl. in-house, via 340B ESP.
Biogen In-House Pharmacy CLD Policy (May 1, 2026) on 340B ESPUCB
June 1, 2026Hospital and grantee CEs with in-house pharmacies: all claim/dispensing data (pharmacy and medical) for 340B-priced drugs, entire portfolio, via 340B ESP within 45 days.
UCB 340B Integrity Policy on 340B ESPAstraZeneca
May 1, 2026Universal claims requirement: all CEs submit 340B pharmacy and medical claims, incl. in-house dispenses, for products in Attachment B, via 340B ESP within 45 days.
AZ In-House Pharmacy Policy (updated June 1, 2026) on 340B ESPBristol Myers Squibb
May 1, 2026All CEs: CLD for all 340B utilization of listed drugs from entity-owned pharmacies and designated CPs, within 45 days.
BMS 340B policy on 340B ESPNovo Nordisk
April 1, 2026All CE types: claims-level data for all in-house pharmacy (and CP) 340B dispenses via 340B ESP within 45 days; annual in-house pharmacy certification.
Novo Nordisk 340B distribution policy pageEli Lilly
February 1, 2026All CE types: pharmacy and medical CLD for all 340B dispenses (incl. in-house), entire portfolio, via 340B ESP within 45 days (60 days for listed products).
Lilly notice Jan 15, 2026 on 340B ESPExelixis
October 1, 2025Claims data for all 340B dispenses, including in-house pharmacy dispenses, via 340B ESP.
Exelixis 340B notice (Sept 3, 2025) on 340B ESPSimple pricing.
$750/month
per covered entity per month
- 2027 340B rebate claim submissions (rebate model).
- In-house pharmacy medical claims submissions to Beacon.
- 340B ESP and Truzo claims data submissions.
- Manufacturer change monitoring included.
- No long setup project.
Already an Aventi TPA client? All of this is included; the price is for covered entities that use another TPA. Learn about 2027 rebate submissions
FAQ
In-house pharmacy medical claims questions
A pharmacy owned and operated by your covered entity (entity-owned), as opposed to a contract pharmacy you partner with.
No. This service works on its own. Keep your current TPA for contract pharmacy and split billing.
See the list above. It changes often, and we track it for you.
Beacon is a 340B claims data platform some manufacturers use to collect claims data. We submit there and to 340B ESP and other channels as required.
$750 per covered entity per month covers 2027 340B rebate claim submissions, current in-house pharmacy medical claims submissions to Beacon, and 340B ESP and Truzo claims data submissions. Already an Aventi TPA client? All of this is included; the price is for covered entities that use another TPA.
Usually a short kickoff call and a data connection with your pharmacy system. We will give you a timeline on the first call.
Want this off your team's plate?
Reply to our email or reach out to Abi Romano. We'll confirm which manufacturers apply to you and get you set up.
abi@aventihealth.com